Amy Simon is Chief Medical Officer of Beam Therapeutics Inc.. Currently has a direct ownership of 68,805 shares of BEAM, which is worth approximately $1.69 Million. The most recent transaction as insider was on Jul 02, 2024, when has been sold 748 shares (Common Stock) at a price of $22.95 per share, resulting in proceeds of $17,166. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.8K
0% 3M change
5.1% 12M change
Total Value Held $1.69 Million

Amy Simon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 02 2024
SELL
Open market or private sale
$17,166 $22.95 p/Share
748 Reduced 1.08%
68,805 Common Stock
Jul 01 2024
SELL
Open market or private sale
$11,927 $23.76 p/Share
502 Reduced 0.72%
69,553 Common Stock
Apr 02 2024
SELL
Open market or private sale
$504,826 $30.54 p/Share
16,530 Reduced 19.09%
70,060 Common Stock
Apr 01 2024
SELL
Open market or private sale
$229,954 $32.13 p/Share
7,157 Reduced 7.63%
86,590 Common Stock
Mar 31 2024
BUY
Grant, award, or other acquisition
-
27,500 Added 22.68%
93,747 Common Stock
Oct 30 2023
SELL
Open market or private sale
$64,477 $18.7 p/Share
3,448 Reduced 5.0%
65,469 Common Stock
Jul 10 2023
SELL
Open market or private sale
$11,917 $30.48 p/Share
391 Reduced 0.56%
68,917 Common Stock
Apr 04 2023
SELL
Open market or private sale
$342,977 $29.43 p/Share
11,654 Reduced 14.39%
69,308 Common Stock
Apr 03 2023
SELL
Open market or private sale
$134,727 $30.31 p/Share
4,445 Reduced 5.2%
80,962 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 19.02%
85,129 Common Stock
AS

Amy Simon

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on BEAM

Follow Beam Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BEAM shares.

Notify only if

Insider Trading

Get notified when an Beam Therapeutics Inc. insider buys or sells BEAM shares.

Notify only if

News

Receive news related to Beam Therapeutics Inc.

Track Activities on BEAM